Thrivent Financial for Lutherans
MYOV

Thrivent Financial for Lutherans’s Myovant Sciences Ltd. MYOV Stock Holding History

Thrivent Financial for Lutherans’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-46,398
Closed -$651K – 2505
2020
Q3 		$651K Sell
46,398
-11,291
-20% -$210K ﹤0.01% 1836
2020
Q2 		$1.19M Hold
57,689
– – ﹤0.01% 1382
2020
Q1 		$436K Buy
+57,689
New +$647K ﹤0.01% 1791

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Thrivent Financial for Lutherans's MYOV Position: Q4 2020 in Review

Thrivent Financial for Lutherans sold out of Myovant Sciences Ltd. (MYOV) in Q4 2020, closing a stake of 46,398 shares — an estimated $651K sold.

Thrivent Financial for Lutherans first reported a position in MYOV in Q1 2020 and held it in 3 quarters. The position peaked at $1.19M in Q2 2020. 105 funds tracked by Wall St. Rank hold MYOV as of Q4 2020.

  • Thrivent Financial for Lutherans reported no remaining Myovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 46,398 Myovant Sciences Ltd. shares in Q4 2020, an estimated $651K.
  • Thrivent Financial for Lutherans first reported a position in Myovant Sciences Ltd. in Q1 2020 and held it in 3 quarters.
  • Thrivent Financial for Lutherans's Myovant Sciences Ltd. position peaked at $1.19M in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2020, filed 16 Feb 2021.